Survival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer
Condition: Advanced Colorectal Carcinoma Interventions: Drug: palliative care group first-line scheme+compound kushen injection; Drug: palliative care group first-line scheme Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academies | Cancer | Cancer & Oncology | Carcinoma | China Health | Colorectal Cancer | Hospitals | Palliative | Palliative Care | Research